Head and neck cancers (HNCs) are a group of heterogeneous tumors formed most
frequently from epithelial cells of the larynx, lips, oropharynx, nasopharynx, and mouth …

Oral squamous cell carcinoma (OSCC) is a kind of malignant tumors with low survival rate
and prone to have early metastasis and recurrence. Cisplatin is an alkylating agent which …

Macroautophagy (autophagy herein) is a cellular stress response and a survival pathway
that is responsible for the degradation of long-lived proteins, protein aggregates, as well as …

Oral cancer is one of the leading cancers in South-Asian countries. Despite the easy access
of the oral cavity, the detection and five year survival rates of OSCC patients are dismal …

Resistance to chemotherapy remains a major obstacle for the effective treatment of oral
squamous cell carcinoma (OSCC). Evidence for the involvement of exosomes as important …

Head and neck squamous cell carcinoma is the sixth most common cancer worldwide, with
890,000 new cases and 450,000 deaths in 2018, and although the survival statistics for …

Oral cancer, represented mainly by oral squamous cell carcinoma (OSCC), is the eighth
most common type of human cancer worldwide. The number of new OSCC cases is …

Oral cancer is the thirteenth most common cancer in the world, with India contributing to 33%
of the global burden. Lack of specific non-invasive markers, non-improvement in patient …

Summary Programmed cell death 4 (PDCD4) is a tumor suppressor gene involved in
tumorogenesis. MicroRNA-21 (miR-21) specifically targets PDCD4, and recent studies …

Cytarabine and daunorubicin are old drugs commonly used in the treatment of acute
myeloid leukaemia (AML). Refractory or relapsed disease because of chemotherapy …